Rocket One Inc. Amortization
Rocket One Inc. (RKTO) reported Amortization of -$8.19 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2025-03-28
- Rocket One Inc. amortization for fiscal 2024 was -$8.19M.
- Rocket One Inc. amortization for fiscal 2023 was -$8.11M.
| Period end | Amortization 12 month |
|---|---|
| 2024-12-31 | -$8.19M 10-K · filed 2025-03-28 |
| 2023-12-31 | -$8.11M 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |